Keita Yamada; Satomi Hyodo; Mitsuhiro Kinoshita; Takao Hayakawa; Kazuaki Kakehi
Analytical Chemistry 82 17 7436 - 7443 2010年09月
[査読有り] We developed an automatic apparatus for the release of O-glycans from mucin-type glycoproteins and proteoglycans (Matsuno, Y.-k.
Yamada, K.
Tanabe, A.
Kinoshita, M.
Maruyama, S.-z.
Osaka, Y.-s.
Masuko, T.
Kakehi, K. Anal. Biochem. 2007, 363, 245-257. Yamada, K.
Hyodo, S.
Matsuno, Y. K.
Kinoshita, M.
Maruyama, S. Z.
Osaka, Y. S.
Casal, E.
Lee, Y. C.
Kakehi, K. Anal. Biochem. 2007, 371, 52-61). The method allows rapid release of O-glycans as the reducing form within 10 min. In the present study, we connected the device to a MALDI-TOF MS spotter and achieved routine analysis of O-glycans in biological samples for clinical use after in situ derivatization of the released O-glycans with phenylhydrazine. We applied the method to the analysis of O-glycans expressed on MKN45 cells derived from human stomach cancer cells and found that MKN45 cells expressed characteristic trisialo-polylactosamine-type glycans as reported previously (Yamada, K.
Kinoshita, M.
Hayakawa, T.
Nakaya, S.
Kakehi, K. J. Proteome Res. 2009, 8, 521-537). We also applied the method to the analysis of O-glycans in serum samples. The present technique is the first attempt to use MS measurement for routine clinical diagnostic works. © 2010 American Chemical Society.